News > Client
SaveE-mailPrintMost PopularRSSReprints

FTC Shuts Down 'Spam Gang'

Oct 16, 2008

- Barry Janoff, Brandweek


NEW YORK Just when you thought no one cared that your e-mail box was overloaded with spam, along comes the Federal Trade Commission to prove you wrong.

The FTC said it has shuttered an operation that sent billions of spam messages around the world directing consumers to Web sites, and that the operation was responsible for as much as a third of the world's spam e-mails. According to the FTC, the operation included participants in Australia, New Zealand, China, India, Russia, Canada and the U.S.

The network was called the largest "spam gang" in the world by the anti-spam organization Spamhaus. The FTC said it has received more than 3 million complaints about spam messages connected to this operation, and estimates that it "may be responsible for sending billions of illegal spam messages." At the request of the FTC, "a U.S. district court has issued a temporary injunction prohibiting defendants from spamming and making false product claims, and has frozen the defendants' assets to preserve them for consumer redress pending trial."

According to the FTC, the defendants include Lance Atkinson, a New Zealand citizen living in Australia, Jody Smith of Texas and four companies they control: Inet Ventures, Tango Pay, Click Fusion and TwoBucks Trading Ltd. The FTC's complaint alleges that both "Atkinson and Smith are liable for the spamming."

The FTC said that the defendants "deceptively marketed a variety of products" through spam messages, including a male-enhancement pill, prescription drugs and a weight-loss pill. One product, VPXL, was touted as an herbal male-enhancement pill, was advertised as "100 percent herbal and safe "and supposedly caused a permanent increase in the size of a user's penis." The FTC alleged that not only did the pills not work, but they were neither "100 percent herbal" nor "safe." The pills were tested by the FDA at the request of the FTC.

The defendants also used spam e-mail to sell prescription drugs and claimed that the medications came from a bona fide, U.S.-licensed pharmacy that dispenses FDA-approved generic versions of drugs such as Levitra, Avodart, Cialis, Propecia, Viagra, Lipitor, Celebrex and Zoloft. According to the FTC, the defendants do not operate a U.S.-licensed pharmacy but do sell drugs that are shipped from India. "The drugs have not been approved by the FDA and are potentially unsafe," according to the FTC.


FTC Shuts Down 'Spam Gang'

Oct 16, 2008

- Barry Janoff, Brandweek


NEW YORK Just when you thought no one cared that your e-mail box was overloaded with spam, along comes the Federal Trade Commission to prove you wrong.

The FTC said it has shuttered an operation that sent billions of spam messages around the world directing consumers to Web sites, and that the operation was responsible for as much as a third of the world's spam e-mails. According to the FTC, the operation included participants in Australia, New Zealand, China, India, Russia, Canada and the U.S.

The network was called the largest "spam gang" in the world by the anti-spam organization Spamhaus. The FTC said it has received more than 3 million complaints about spam messages connected to this operation, and estimates that it "may be responsible for sending billions of illegal spam messages." At the request of the FTC, "a U.S. district court has issued a temporary injunction prohibiting defendants from spamming and making false product claims, and has frozen the defendants' assets to preserve them for consumer redress pending trial."

According to the FTC, the defendants include Lance Atkinson, a New Zealand citizen living in Australia, Jody Smith of Texas and four companies they control: Inet Ventures, Tango Pay, Click Fusion and TwoBucks Trading Ltd. The FTC's complaint alleges that both "Atkinson and Smith are liable for the spamming."

The FTC said that the defendants "deceptively marketed a variety of products" through spam messages, including a male-enhancement pill, prescription drugs and a weight-loss pill. One product, VPXL, was touted as an herbal male-enhancement pill, was advertised as "100 percent herbal and safe "and supposedly caused a permanent increase in the size of a user's penis." The FTC alleged that not only did the pills not work, but they were neither "100 percent herbal" nor "safe." The pills were tested by the FDA at the request of the FTC.

The defendants also used spam e-mail to sell prescription drugs and claimed that the medications came from a bona fide, U.S.-licensed pharmacy that dispenses FDA-approved generic versions of drugs such as Levitra, Avodart, Cialis, Propecia, Viagra, Lipitor, Celebrex and Zoloft. According to the FTC, the defendants do not operate a U.S.-licensed pharmacy but do sell drugs that are shipped from India. "The drugs have not been approved by the FDA and are potentially unsafe," according to the FTC.


Post a Comment
Asterisk (*) is a required field.
* Author:
* Comment:
 
The opinions expressed in comments are those of the individual poster. They do not necessarily reflect the views of Adweek or Nielsen Business Media. Attacks of a personal nature and comments that are otherwise inappropriate may be removed.

Other Client News

unilever

Unilever's CMO to Step Down

February 09, 2010

Simon Clift is stepping down as chief marketing officer of Unilever in the next few months, the company has confirmed. Read Full Article



Our ProductsOur Products

ADWEEK DAILY UPDATE

Receive a comprehensive roundup of the biggest stories of the day.

BREAKING NEWS ALERTS

Sign up to be the first to hear about the biggest breaking news stories.

SUBSCRIBE

Stay connected to what's happening in the advertising industry with delivery of the print edition and complete online access.

More VideosVideo





Adweek Advertising Home | Advertising Industry News | Creative TV Advertising | Advertising Industry Community | Video Advertising | Advertising Data Center | Advertising Special Reports | Advertising Careers | Advertising Products | Advertising About Us | Advertising Business Statements | Advertising Contact Us | Advertising Opportunities | Ad Licensing | Advertiser FAQ | Advertising Magazine Subscriptions | Advertising News RSS | Online Ad Site Map | Mobile

© 2010 Adweek. All rights reserved. Terms of Use  |   Privacy Policy